The expression of the PTPN6 gene was also significantly reduced in CD34‐positive cells isolated from the blood of JAK2V617F‐mutated MPN patients (1 ET, 4 PV, 3 MF) compared to healthy donors of similar ages (Figure 2F). This evidence concerns the gene PTPN6 and myeloproliferative neoplasm.